Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights

Initial AlloNK® (AB-101) clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months ...

Jon Krakauer on his Everest climb: 'I wish I'd never gone'

Writer Jon Krakauer was there as a client of Kiwi Rob Hall’s Adventure Consultants on assignment for Outside, and the ...

Artiva Biotherapeutics, Inc.: Artiva Announces Positive Initial Clinical Data with AlloNK Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 ...

Initial clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in the company-sponsored Phase 2a basket trial, with no pat ...

Falling prices, broad use scenarios fuel Chinese adoption of humanoid robots

Driven by constant tech breakthroughs and growing market adoption, humanoid robots in China are undergoing a notable wave of ...

Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid ...

Initial clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in ...
LAist

Warm Mothers Day Weekend

The backstory: Arts programming is a long Olympic tradition — starting in 1912 as artistic competitions and eventually ...